Bio-View Ltd (TLV:BIOV)
5,025.00
+259.00 (5.43%)
Nov 12, 2026, 5:24 PM IST
Bio-View Market Cap
Bio-View has a market cap or net worth of 6.73 million as of November 12, 2026. It is the 48,006th most valuable company in the world and the 494th biggest in Israel. Its market cap has decreased by 65.10% in one year.
Market Cap
6.73M
Enterprise Value
1.67M
Revenue
20.70M
Global Rank
Country Rank
#494 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 6.73M, a decrease of -88.74%. That is a compound annual growth rate of -10.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 6.73M | -69.91% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.42B |
| Amal Holdings A.D. | 2.19B |
| Rafa Laboratories | 1.65B |
| BrainsWay | 1.53B |
| Can-Fite BioPharma | 17.09M |
| Evogene | 14.08M |
| PsyRX CNS Bio-Tech | 9.22M |
| MediPress Health-Limited Partnership | 6.67M |